Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cidara Therapeutics Inc.

www.cidara.com

Latest From Cidara Therapeutics Inc.

Latest Phase II Data Bolster Cidara’s Antifungal

Cidara Therapeutics said new top-line results from the Phase II trial evaluating its lead asset as a first-line antifungal treatment in patients with candidemia and invasive candidiasis supported its ongoing Phase III ReSTORE program.
Clinical Trials Commercial

Antibiotic Incentives: Advocates Sounding The Alarm For DISARM

Antibiotic developers have a blunt message for Congress: the time for action is now or never. They see a targeted reimbursement change (The DISARM Act) as vital to send a signal to investors that the sector can be saved – and don’t want to delay to debate other ideas like “subscription” models.

Infectious Diseases Legislation

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  
Drug Review Biosimilars

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  
Drug Review Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • K2 Therapeutics
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cidara Therapeutics Inc.
  • Senior Management
  • Jeffrey Stein, PhD, Pres. & CEO
    Matt Onaitis , CFO
    Taylor Sandison, MD, CMO
    Ken Bartizal, Chief Dev. Officer
    Paul Daruwala, Chief Commercial Officer
    James Balkovec, PhD, SVP, Rsch.
  • Contact Info
  • Cidara Therapeutics Inc.
    Phone: (858) 752-6170
    6310 Nancy Ridge Dr.
    Ste. 101
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register